Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015-Reference-Cited by-同舟云学术

Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015

Published:2015-12-03 Issue:48 Volume:20 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Brown Rebecca J¹²,Macfarlane-Smith Louissa³,Phillips Sarah¹,Chalker Victoria J¹

Affiliation:

1. Bacteriology Reference Department, Public Health England (PHE), London, United Kingdom

2. Cardiff University School of Medicine, Department of Child Health, University Hospital of Wales, Cardiff, United Kingdom

3. Department of Microbiology, Leeds General Infirmary, Leeds, United Kingdom

Abstract

Mycoplasma pneumoniae infection can cause pneumonia, particularly in children. Global increase in macrolide-resistant M. pneumoniae is of concern due to limited therapeutic options. We describe the detection of macrolide resistance-conferring mutations in 9.3% of 43 clinical specimens where M. pneumoniae was detected in England and Wales from September 2014‒September 2015. This study aims to impact by highlighting the presence of macrolide resistance in M. pneumoniae positive patients, promoting increased clinical vigilance.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference22 articles.

1. Macrolide resistant Mycoplasma pneumoniae in England and Wales: Abstract P724, 22nd European Congress of Clinical Microbiology and Infectious Diseases.;Chalker;Clin Microbiol Infect,2012

2. Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK.;Ferguson;J Med Microbiol,2013

3. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.;Li;Pediatr Infect Dis J,2009

4. Mycoplasma pneumoniae and respiratory virus infections in children with persistent cough in England: a retrospective analysis.;Wang;Pediatr Infect Dis J,2011

5. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia.;Narita;J Infect Chemother,2010

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrolide-resistant Mycoplasma pneumoniae: Do we know the situation in Europe?;Revista Española de Quimioterapia;2023-03-27

2. Epidemic characteristics of Mycoplasma pneumoniae infection: a retrospective analysis of a single center in Suzhou from 2014 to 2020;Annals of Translational Medicine;2022-10

3. Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis;Journal of Antimicrobial Chemotherapy;2022-06-09

4. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021;Eurosurveillance;2022-05-12

5. Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae;Journal of Clinical Medicine;2022-03-24